You are here

biologics

GSK, Sanofi, Takeda sign with Singapore partnership to advance biologic manufacturing

Fierce Pharma

Tue, 12/6/22 - 08:54 pm

A biologic’s efficacy in a pill: Dice posts first human data for oral psoriasis med

MedCity News

Tue, 10/11/22 - 03:59 pm

DiCE Therapeutics

Novartis investing US$300m in next generation biotherapeutics development

Biopharma Reporter

Mon, 09/19/22 - 09:14 am

biotherapeutics

drug development

Novartis funnels $300M into early biologic drug manufacturing

BioPharma Dive

Mon, 09/12/22 - 11:36 pm

drug manufacturing

Horizon charts massive biologics expansion in Ireland, where it'll add 350 new jobs

Fierce Pharma

Mon, 08/29/22 - 10:51 am

drug manufacturing

Catalent buys partially built biologics plant with plans to shell out $160M to finish it

Fierce Pharma

Thu, 04/7/22 - 10:32 am

drug manufacturing

Catalent completes $30m expansion to biologics network

Biopharma Reporter

Tue, 03/22/22 - 10:03 am

drug manufacturing

J&J's long-acting injectable push barrels forward as it adds 2nd large molecule to Midatech pact

Fierce Biotech

Wed, 03/9/22 - 10:56 am

Recipharm grows biologics business as it acquires Arranta Bio and Vibalogics

Biopharma Reporter

Fri, 02/18/22 - 10:28 am

Biologics CDMO market is expanding rapidly but is challenged by capacity constraints

Biopharma Reporter

Tue, 02/15/22 - 11:26 pm

Eli Lilly plans €400m Irish plant that will create 800 jobs

Pharmaforum

Fri, 01/28/22 - 10:13 am

drug manufacturing

Merck will support Saudi Arabia effort to build biologics manufacturing operations

Fierce Pharma

Wed, 11/3/21 - 11:36 pm

Physicians hesitant to switch patients from biologics to biosimilar drugs, report finds

Beckers Hospital Review

Mon, 09/27/21 - 10:55 am

Repligen sees $150M Avitide acquisition as key to reaching gene therapy goals

MedCity News

Mon, 09/20/21 - 12:06 am

Biosimilars versus biologics: Is marketing madness on the way as biosimilar approvals balloon?

Fierce Pharma

Tue, 08/17/21 - 10:13 am

Bristol Myers' next-gen immunology med busts Amgen's Otezla in head-to-head study. Is a showdown coming?

Endpoints

Fri, 04/23/21 - 11:12 am

Bristol Myers Squibb

deucravacitinib

Special Counsel raises questions about FDA’s biologics inspections

RAPS.org

Thu, 04/1/21 - 10:56 am

regulatory inspections

FDA Approves First Biologic for Rare, Debilitating Lung Disease

BioSpace

Sun, 03/7/21 - 01:35 pm

AbbVie sells biologics plant to Pharmaron, fueling the China company's cell and gene therapy ambitions

Fierce Pharma

Tue, 03/2/21 - 11:52 pm

drug manufacturing

Ireland is open: The biologics boom boosting the Irish economy

Pharmaforum

Fri, 02/12/21 - 10:51 am

Pages